Precision subclassification of type 2 diabetes: a systematic review
Background Heterogeneity in type 2 diabetes presentation and progression suggests that
precision medicine interventions could improve clinical outcomes. We undertook a …
precision medicine interventions could improve clinical outcomes. We undertook a …
Machine and deep learning for longitudinal biomedical data: a review of methods and applications
A Cascarano, J Mur-Petit… - Artificial Intelligence …, 2023 - Springer
Exploiting existing longitudinal data cohorts can bring enormous benefits to the medical
field, as many diseases have a complex and multi-factorial time-course, and start to develop …
field, as many diseases have a complex and multi-factorial time-course, and start to develop …
The identification of diabetes mellitus subtypes applying cluster analysis techniques: a systematic review
A Sarría-Santamera, B Orazumbekova… - International Journal of …, 2020 - mdpi.com
Diabetes Mellitus is a chronic and lifelong disease that incurs a huge burden to healthcare
systems. Its prevalence is on the rise worldwide. Diabetes is more complex than the …
systems. Its prevalence is on the rise worldwide. Diabetes is more complex than the …
Exploring alternative approaches to precision medicine through genomics and artificial intelligence–a systematic review
H Mumtaz, M Saqib, S Jabeen, M Muneeb… - Frontiers in …, 2023 - frontiersin.org
The core idea behind precision medicine is to pinpoint the subpopulations that differ from
one another in terms of disease risk, drug responsiveness, and treatment outcomes due to …
one another in terms of disease risk, drug responsiveness, and treatment outcomes due to …
Clinical phenotypes in patients with type 2 diabetes mellitus: characteristics, cardiovascular outcomes and treatment strategies
Abstract Purpose of Review With recent advances in the pharmacological management of
type 2 diabetes mellitus (T2DM), there is a growing need to understand which patients …
type 2 diabetes mellitus (T2DM), there is a growing need to understand which patients …
Prediction of treatment outcome in clinical trials under a personalized medicine perspective
A central problem in most data-driven personalized medicine scenarios is the estimation of
heterogeneous treatment effects to stratify individuals into subpopulations that differ in their …
heterogeneous treatment effects to stratify individuals into subpopulations that differ in their …
Predicting short‐and long‐term glycated haemoglobin response after insulin initiation in patients with type 2 diabetes mellitus using machine‐learning algorithms
SB Nagaraj, G Sidorenkov… - Diabetes, Obesity and …, 2019 - Wiley Online Library
Aim To assess the potential of supervised machine‐learning techniques to identify clinical
variables for predicting short‐term and long‐term glycated haemoglobin (HbA1c) response …
variables for predicting short‐term and long‐term glycated haemoglobin (HbA1c) response …
Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Purpose This scoping review summarizes the applications of artificial intelligence (AI) and
bioinformatics methodologies in analysis of ocular biofluid markers. The secondary objective …
bioinformatics methodologies in analysis of ocular biofluid markers. The secondary objective …
The present and future scope of real‐world evidence research in diabetes: what questions can and cannot be answered and what might be possible in the future?
The last decade has witnessed an exponential growth in the opportunities to collect and link
health‐related data from multiple resources, including primary care, administrative, and …
health‐related data from multiple resources, including primary care, administrative, and …
An affordable approach to classifying type 2 diabetes based on fasting plasma glucose, TyG index and BMI: a retrospective cohort study of NHANES Data from 1988 to …
J Xie, X Zhang, H Shao, S Jing, T Shan, Y Shi… - Diabetology & Metabolic …, 2022 - Springer
Background The β-cell function and insulin resistance required by existing methods of
classifying type 2 diabetes are not routinely adopted in most medical institutions of …
classifying type 2 diabetes are not routinely adopted in most medical institutions of …